Unlocking Patient Engagement: Enhancing the Clinical Trial Experience with Consumerization

Clincierge reports that 87 percent of patients and their families find participating in clinical trials to be a stressful experience. Moreover, with a staggering 85 percent of Americans owning a smartphone, many in the industry believe they can be used to improve clinical trial experiences and patient engagement.

This rise in technology adoption has also raised the expectations of trial participants, who now seek simpler, more consumer-like experiences in clinical design.

In the future, patient participation in clinical trials could be as simple as ordering from their favorite food delivery app or online shopping site. However, it takes an industry to realize this.

In this webinar, a panel of industry experts will cover how trials have already changed, what past examples show about future change, what tech to seek out and what to avoid.

Join this webinar to discover the future of clinical trials. Understand the impact of consumer-like experiences and technology on patient engagement.

Speakers

Mike Decastro, Head of Sales, Uber Health

Mike is currently the Head of Sales at Uber Health, working with Health Systems, Health Plans, and risk bearing organizations to address social determinants of health through Uber’s transportation and delivery solutions. Prior to Uber, Mike held various commercial roles within the medical device and digital health industries with market leaders including Smith & Nephew, Topcon, and GoCheck Kids. He resides in Washington, D.C. with his wife Christina and 2 year old son Christopher.

Message Presenter

Shawn Tedman, VP of Biopharma Innovation, ixlayer

Shawn Tedman has deep clinical development and technology expertise gained from roles in biopharmaceutical, contract research, and most recently health technology organizations. He has built and scaled global feasibility, site intelligence and clinical technology teams with a focus on patient-centricity, diversity, and real world data insights. In his current role at ixlayer, Shawn partners with innovative life science organizations to reduce barriers between patients and the health tests they need.

Message Presenter

Aadhar Shah, VP of New Markets, Medable

Aadhar Shah is Medable’s Vice President of Growth & Strategy, where his mandate is to drive market strategy and structure value at scale for enterprise customers. His career has focused on life sciences, healthcare, digital, and data to construct multiplier opportunities at the intersection of these fields to create step-change for the ultimate benefit of patients and their health, with a focus on sustainable business outcomes.

Message Presenter

(Moderator) Colin Weller, GM of Evidence Generation, Medable

Colin has worked in the Drug Development industry for more than 20 years having spent large portions of time with Big Pharma and Biotech companies such as Pfizer, Amgen and AstraZeneca.

Message Presenter